Top Searches
May 18, 2012
| PharmaWeek > Pfizer Acquires Rights to Alzheimer’s Drug



Pfizer Acquires Rights to Alzheimer’s Drug


Sept. 4 – Pfizer said Wednesday that it was acquiring the rights to a promising experimental drug for Alzheimer’s disease from Medivation for as much as $725 million. New York Times.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1
White Papers & Special Reports

isilon_emc_thumbnail
Hadoop’s Rise in Life Sciences
Sponsored by EMC Isilon
COMPLIMENTARY DOWNLOAD


tessella_whp_image
The Case for Digital Archiving in Life Sciences
Sponsored by Tessella
COMPLIMENTARY DOWNLOAD


sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI
COMPLIMENTARY DOWNLOAD
More White Papers & Special Reports
Life Science Webcasts & Podcasts

medidata_podcast_Sites and Sponsors: Mending Bridges over Troubled Waters  
Sites and Sponsors: Mending Bridges over Troubled Waters
Sponsored by Medidata Solutions Worldwide

This podcast brings together two industry leaders to focus on the issues that divide sponsors and sites. On the one hand sites and sponsors unite in advancing better health care through a common passion for developing better drugs. Yet some issues divide them and bridges need to be built or mended to advance the highest levels of cooperation, coordination and success in clinical trials. Listen as the key issues are debated from the site and the sponsor side and new methods and technology are advanced that offer near-term and lasting solutions.

• Common ground in reaching agreement on a budget

• Improving the pace of agreement on budgets and contracts

• Processes for payment to sites on a timely basis

Listen Now  

More Podcasts

Job Openings

Firmenich
PhD COMPUTATIONAL SYSTEMS SCIENTIST
To review full job description please go to www.Firmenich.com and search for Computational Biologist. All qualified candidates send updated resume to ppapiccio@agile1.com.
read more
abbott labs
Abbott Labs, Health Informatics Program ManagerQualified candidates may apply by posting their resume to www.abbott.com/careers. Reference number: 110844BR.
read more

Sponsored Links
RELATED
RESOURCES & PRODUCTS
Potential Breakthroughs in Neurotherapeutics: Alzheimer's Disease, Parkinson's Disease, Depression, Bipolar Disorder, and Schizophrenia
Potential Breakthroughs in Neurotherapeutics: Alzheimer's Disease, Parkinson's Disease, Depression, Bipolar Disorder, and Schizophrenia
Biomarkers in Drug Development
Antibody Drug Conjugates
Antibody Drug Conjugates

RELATED STORIES

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com . 

Cambridge Healthtech Institute

Footer Image
  • 250 First Avenue, Suite 300
  • Needham MA 02494
  • phone: 781-972-5400
  • fax: 781-972-5425
  • chi@healthtech.com